Skip to main content
SpringerLink
Log in
Book cover
  • Book
  • © 2016

Hepatocellular Carcinoma

Diagnosis and Treatment

Editors:

  1. Brian I. Carr

    1. Dokuz Eylul University, Izmir Biomedicine and Genome Center Dokuz Eylul University, Izmir, Turkey

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Provides the reader with a clear understanding of the many mechanisms involved in carcinogenesis of the liver
  • Comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma
  • Written by international leaders in the field Updated and enhanced new edition covering topics such as global epidemiology, environmental carcinogens and diet, CT imaging, vascular radiology, and psychological factors
  • Vital resource for today's hepatologists and medical and surgical oncologists
  • Includes supplementary material: sn.pub/extras

Part of the book series: Current Clinical Oncology (CCO)

Sections

Buy it now

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (37 chapters)

  1. Front Matter

    Pages i-xxi
    PDF

  2. Causes, Biological and Molecular Bases of HCC

    1. Front Matter

      Pages 1-1
      PDF

    2. Epidemiology of Hepatocellular Carcinoma

      • Donna L. White, Fasiha Kanwal, Li Jiao, Hashem B. El-Serag
      Pages 3-24

    4. Molecular Mechanisms of Hepatocellular Carcinoma

      • Hani Alotaibi, Nese Atabey, Kasım Diril, Esra Erdal, Mehmet Ozturk
      Pages 43-63

    5. Chemically-Induced Hepatocarcinogenesis

      • Yvonne P. Dragan
      Pages 65-92

    6. Molecular Profiling of Human Hepatocellular Carcinoma

      • Anuradha Budhu, Xin Wei Wang
      Pages 93-112

    7. Genomic Signatures of Risk Factors and Molecular Identification of HCC Subtypes

      • Jean-Charles Nault, Jessica Zucman-Rossi
      Pages 113-119

    8. MicroRNAs and Hepatocellular Carcinoma

      • Aldo Cavallini
      Pages 121-137

    9. Nontumor Prognostic Factors in Hepatocellular Carcinoma

      • Nicolas Goossens, Ismail Labgaa, Augusto Villanueva
      Pages 139-147

    10. Gut Microbiota and HCC

      • Sven H. Loosen, Christoph Roderburg, Tom Luedde
      Pages 149-155

    11. Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer

      • Antonio Mazzocca, Giovanni Ferraro, Giovanni Misciagna, Brian I. Carr
      Pages 157-161

    12. HCC and Its Microenvironment

      • Brian I. Carr
      Pages 163-166

    15. Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma

      • Evgeny V. Denisov, Tatiana S. Gerashchenko, Marina V. Zavyalova, Vasiliy N. Manskikh, Evgeny L. Choinzonov, Nadezhda V. Cherdyntseva et al.
      Pages 211-228

    17. Hepatocellular Carcinoma Associated with Hepatitis B Virus

      • Inbal Houri, Oren Shibolet
      Pages 243-259

    18. Hepatitis C and Hepatocellular Carcinoma

      • Ryota Masuzaki, Tatsuo Kanda, Haruhiko Yoshida, Naoya Kato, Masao Omata
      Pages 261-273

    19. Obesity, NASH, and HCC

      • Chadia L. Robertson, Devanand Sarkar, Arun J. Sanyal
      Pages 275-286
Back to top

About this book

• Hepatocellular carcinoma (HCC) used to be regarded as a rare disease. However, the increasing numbers of chronic HCC carriers in the U.S. and subsequent increased incidences of HCC seen in most large medical centers means that it is no longer an uncommon disease for gastroenterologists or oncologists to encounter and its incidence and epidemiology are changing. During this exciting time in the field of HCC basic science and clinical management, many changes are simultaneously occurring at multiple levels of our understanding and management of the disease. Suddenly, there are several new choices of therapy to offer patients. Hepatocellular Carcinoma, 3rd edition addresses this fast-changing disease and gives the reader a clearer understanding of the many mechanisms involved in carcinogenesis of the liver. This comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma is written by international leaders in the field, covering both clinical treatment choices and the basic science underlying HCC development. Updated and enhanced from the last edition in 2009, Hepatocellular Carcinoma, 3rd edition features 12 new chapters including discussion of molecular markers, molecular hepatocarcinogenesis, microenvironment, heterogeneity, the new and exciting contributions of immunotherapy, and updates on the major effective hepatitis therapies that will transform HCC incidence and perhaps also the therapy. This cutting-edge text is a vital resource and must-have for today’s hepatologists and medical and surgical oncologists. 




"This is a well written text and should be a good reference book for those who see patients with HCC.." - Practical Gastroenterology



"...a useful tool for both physicians and surgeons with a specific interest in the management of patients with HCC." - Digestive and Liver Disease
Back to top

Keywords

Back to top

Reviews











Back to top

Editors and Affiliations

  • Dokuz Eylul University, Izmir Biomedicine and Genome Center Dokuz Eylul University, Izmir, Turkey

    Brian I. Carr

Back to top

About the editor

Dr. Brian I. Carr is Professor of Medical Oncology, Thomas Jefferson University, Philadelphia and Professor, IRCCS de Bellis, National Institute for Digestive Diseases, Castellana Grotte (BA), Italy. Since 1977 he has devoted both his clinical activities and research science efforts to the clinical and scientific study of primary liver cancer (HCC or hepatocellular carcinoma). He has published more than 250 papers in peer-reviewed journals, over 350 abstracts and given a similar number of meeting presentations, written chapters in 36 books and edited 2 books. He is guest editor for the HCC special issue of Seminars in Oncology, Aug, 2012 and has written the chapter on HCC for the last 2 editions of Harrison’s Internal Medicine.
Back to top

Bibliographic Information

  • Book Title: Hepatocellular Carcinoma

  • Book Subtitle: Diagnosis and Treatment

  • Editors: Brian I. Carr

  • Series Title: Current Clinical Oncology

  • DOI: https://doi.org/10.1007/978-3-319-34214-6

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2016

  • Hardcover ISBN: 978-3-319-34212-2Published: 07 September 2016

  • Softcover ISBN: 978-3-319-81705-7Published: 12 June 2018

  • eBook ISBN: 978-3-319-34214-6Published: 26 August 2016

  • Series ISSN: 2364-1134

  • Series E-ISSN: 2364-1142

  • Edition Number: 3

  • Number of Pages: XXI, 596

  • Number of Illustrations: 49 b/w illustrations, 80 illustrations in colour

  • Topics: Oncology, Hepatology, Surgical Oncology, Gastroenterology

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Back to top

Publish with us

Policies and ethics

Back to top
Access via your institution

Buy it now

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Search

Navigation